Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration (Q28263954)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

object named as

Michael Kundi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Katja Haas

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Wolfgang R Sperr

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Harald Esterbauer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Wolf-Dieter Ludwig

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Richard Ratei

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Elisabeth Koller

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Helga Gruener

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cristina Sauerland

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Christa Fonatsch

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Genes, Chromosomes and Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

288-298

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

EVI1 induces myelodysplastic syndrome in mice

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

21 January 2018

Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

21 January 2018

t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

21 January 2018

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

EVI1 abrogates interferon-alpha response by selectively blocking PML induction

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

EVI1 promotes cell proliferation by interacting with BRG1 and blocking the repression of BRG1 on E2F1 activity

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute leukemia with structural rearrangements of chromosome 3.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

EVI1 expression in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20532

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GCC.20532

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18181178%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28263954&oldid=1507958767"